Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin M Wilfong

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Therapeutic Advances in Musculoskeletal Disease|December 17, 2021
Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung diseaseErin M Wilfong, Rohit Aggarwal
Best Practice & Research. Clinical Rheumatology|March 20, 2013
Vasculitis in the intensive care unitErin M Wilfong, Philip Seo
The Lancet. Respiratory Medicine|November 14, 2021
Intravenous immunoglobulin therapy for COVID-19 ARDSErin M Wilfong, Michael A Matthay
Bioorganic & Medicinal Chemistry Letters|September 19, 2012
An enthalpic basis of additivity in biphenyl hydroxamic acid ligands for stromelysin-1Erin M Wilfong, Yu Du, Eric J Toone
Bioorganic & Medicinal Chemistry Letters|November 28, 2009
A single step purification for autolytic zinc proteinasesErin M Wilfong, Ursala Locklear, Eric J Toone
Arthritis & Rheumatology (Hoboken, N.J.)|August 13, 2019
ReplyErin M Wilfong, Leslie J Crofford, Jonathan A Kropski
Arthritis & Rheumatology (Hoboken, N.J.)|November 20, 2018
ReplyErin M Wilfong, Kevin W Bayram, Leslie J Crofford
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 25, 2022
Multiparameter analysis of human B lymphocytes identifies heterogeneous CD19<sup>+</sup> CD21<sup>lo</sup> subsetsErin M Wilfong, Katherine N Vowell, Leslie J Crofford, et al.
Frontiers in Immunology|April 23, 2026
B cells in anti-tRNA synthetase syndrome patients show an activated, interferon-responsive signatureErin M Wilfong, Lindsay E Bass, Leslie J Crofford, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 23, 2018
Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unitJulio A Huapaya, Erin M Wilfong, Christopher T Harden, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Musculoskeletal Disease|December 17, 2021
Role of antifibrotics in the management of idiopathic inflammatory myopathy associated interstitial lung diseaseErin M Wilfong, Rohit Aggarwal
Best Practice & Research. Clinical Rheumatology|March 20, 2013
Vasculitis in the intensive care unitErin M Wilfong, Philip Seo
The Lancet. Respiratory Medicine|November 14, 2021
Intravenous immunoglobulin therapy for COVID-19 ARDSErin M Wilfong, Michael A Matthay
Bioorganic & Medicinal Chemistry Letters|September 19, 2012
An enthalpic basis of additivity in biphenyl hydroxamic acid ligands for stromelysin-1Erin M Wilfong, Yu Du, Eric J Toone
Bioorganic & Medicinal Chemistry Letters|November 28, 2009
A single step purification for autolytic zinc proteinasesErin M Wilfong, Ursala Locklear, Eric J Toone
Arthritis & Rheumatology (Hoboken, N.J.)|August 13, 2019
ReplyErin M Wilfong, Leslie J Crofford, Jonathan A Kropski
Arthritis & Rheumatology (Hoboken, N.J.)|November 20, 2018
ReplyErin M Wilfong, Kevin W Bayram, Leslie J Crofford
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|October 25, 2022
Multiparameter analysis of human B lymphocytes identifies heterogeneous CD19<sup>+</sup> CD21<sup>lo</sup> subsetsErin M Wilfong, Katherine N Vowell, Leslie J Crofford, et al.
Frontiers in Immunology|April 23, 2026
B cells in anti-tRNA synthetase syndrome patients show an activated, interferon-responsive signatureErin M Wilfong, Lindsay E Bass, Leslie J Crofford, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 23, 2018
Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unitJulio A Huapaya, Erin M Wilfong, Christopher T Harden, et al.
Pageof 4